Traws Pharma, Inc.
TRAW
$0.83
-$0.01-0.60%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | 0.00 | -- | 2.73M | 57.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 0.00 | -- | 2.73M | 57.00K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | 0.00 | -- | 2.73M | 57.00K |
| SG&A Expenses | 2.03M | 2.33M | 1.74M | 1.69M | 2.75M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.95M | 7.37M | 4.06M | 3.98M | 5.26M |
| Operating Income | -6.95M | -7.37M | -4.06M | -1.25M | -5.20M |
| Income Before Tax | -7.11M | -7.44M | -3.96M | -915.00K | 21.49M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.11M | -7.44M | -3.96M | -915.00K | 21.49M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.11M | -7.44M | -3.96M | -915.00K | 21.49M |
| EBIT | -6.95M | -7.37M | -4.06M | -1.25M | -5.20M |
| EBITDA | -6.90M | -7.32M | -4.04M | -1.25M | -5.20M |
| EPS Basic | -0.53 | -0.58 | -0.34 | -0.11 | 2.17 |
| Normalized Basic EPS | -0.42 | -0.50 | -0.28 | -0.10 | 1.93 |
| EPS Diluted | -0.53 | -0.58 | -0.34 | -0.11 | 2.09 |
| Normalized Diluted EPS | -0.42 | -0.50 | -0.28 | -0.10 | 1.86 |
| Average Basic Shares Outstanding | 10.64M | 9.36M | 8.82M | 5.82M | 6.97M |
| Average Diluted Shares Outstanding | 10.64M | 9.36M | 8.82M | 5.82M | 7.22M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |